Two Sigma Investments, LP Benitec Biopharma Inc. Transaction History

Two Sigma Investments, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.18 - $0.36 $397 - $794	-2,206 Reduced 7.62%	26,747 $5,000
Q4 2022 Feb 14, 2023	SELL	$0.13 - $5.95 $1,285 - $58,815	-9,885 Reduced 25.45%	28,953 $4,000
Q3 2022 Nov 14, 2022	BUY	$0.31 - $6.32 $12,039 - $245,456	38,838 New	38,838 $14,000
Q1 2021 May 17, 2021	SELL	$2.59 - $9.26 $147,964 - $529,014	-57,129 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.61 - $4.79 $149,106 - $273,647	57,129 New	57,129 $171,000

1.42M

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $280M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.